Hopefully the trend will remain positive overall. One would think ADA SOC, etc., should allow continued progress with prescriptions in the near term.
It feels like more and more what is really going to matter is everything after approval of the expanded label, including the script numbers. All is fine even with these numbers if you're holding long term in my opinion.